Nature's Response To Man-Made Pollution Needs More Man-Made Funding Support

The celebration of Earth Day in April reminded us of the importance of a healthful environment and focused attention on natural biological processes that prevent or minimize environmental contamination. Bioremediation is just such a process. It offers promise great enough to have spawned a growing industry. The industry's representatives met recently in Washington, D.C., with officials of the U.S. Environmental Protection Agency (EPA) to confer on bioremediation and its future applications. Bi

Written byDavid Pramer
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The celebration of Earth Day in April reminded us of the importance of a healthful environment and focused attention on natural biological processes that prevent or minimize environmental contamination. Bioremediation is just such a process. It offers promise great enough to have spawned a growing industry. The industry's representatives met recently in Washington, D.C., with officials of the U.S. Environmental Protection Agency (EPA) to confer on bioremediation and its future applications.

Bioremediation is the use of biological agents to reclaim polluted soils and waters. This process is effective and relatively inexpensive compared to other degradative processes, such as incineration. Bioremediation occurs at the site of contamination, so costly collection and delivery of materials are eliminated. In addition, bioremediation requires only simple and readily available equipment.

The biological agents used for bioremediation are most frequently microorganisms that degrade pollutants. These microorganisms, commonly bacteria and fungi, may be indigenous to the contaminated ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies